CC
BIIB icon

Centiva Capital’s Biogen BIIB Stock Holding History

Centiva Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,858
Closed -$284K – 1573
2024
Q4 		$284K Sell
1,858
-4,487
-71% -$757K 0.01% 1169
2024
Q3 		$1.23M Buy
6,345
+4,108
+184% +$859K 0.02% 728
2024
Q2 		$519K Buy
+2,237
New +$486K 0.01% 1131
2023
Q4 		– Sell
-2,013
Closed -$517K – 1812
2023
Q3 		$517K Buy
+2,013
New +$538K 0.01% 941
2023
Q1 		– Sell
-6,038
Closed -$1.67M – 1526
2022
Q4 		$1.67M Buy
6,038
+3,584
+146% +$1.01M 0.05% 410
2022
Q3 		$655K Sell
2,454
-17,711
-88% -$3.76M 0.01% 785
2022
Q2 		$4.11M Sell
20,165
-4,804
-19% -$982K 0.1% 185
2022
Q1 		$5.26M Buy
24,969
+15,466
+163% +$3.36M 0.1% 161
2021
Q4 		$2.28M Buy
9,503
+4,665
+96% +$1.2M 0.05% 334
2021
Q3 		$1.37M Buy
4,838
+2,966
+158% +$972K 0.09% 226
2021
Q2 		$648K Buy
+1,872
New +$567K 0.02% 731
2021
Q1 		– Sell
-4,610
Closed -$1.13M – 1152
2020
Q4 		$1.13M Sell
4,610
-6,070
-57% -$1.57M 0.04% 245
2020
Q3 		$3.03M Buy
10,680
+2,905
+37% +$810K 0.2% 83
2020
Q2 		$2.08M Buy
7,775
+5,388
+226% +$1.62M 0.13% 97
2020
Q1 		$755K Sell
2,387
-7,946
-77% -$2.41M 0.03% 264
2019
Q4 		$3.07M Sell
10,333
-4,455
-30% -$1.24M 0.15% 134
2019
Q3 		$3.44M Buy
14,788
+14,755
+44,712% +$3.44M 0.21% 96
2019
Q2 		$8K Sell
33
-1,884
-98% -$435K ﹤0.01% 419
2019
Q1 		$453K Buy
+1,917
New +$604K 0.03% 234

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Centiva Capital's BIIB Position: Q1 2025 in Review

Centiva Capital sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,858 shares — an estimated $284K sold.

Centiva Capital first reported a position in BIIB in Q1 2019 and held it in 19 quarters. The position peaked at $5.26M in Q1 2022. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Centiva Capital reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 1,858 Biogen shares in Q1 2025, an estimated $284K.
  • Centiva Capital first reported a position in Biogen in Q1 2019 and held it in 19 quarters.
  • Centiva Capital's Biogen position peaked at $5.26M in Q1 2022.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.